OCT4‑positive circulating tumor cells may predict a poor prognosis in patients with metastatic castration‑resistant prostate cancer treated with abiraterone plus prednisone therapy

Octamer-binding transcription factor 4 (OCT4) and circulating tumor cells (CTCs) are key factors associated with tumor metastasis and drug resistance in cancer. The present prospective study aimed to investigate the prevalence of OCT4-positive (OCT4(+)) CTCs and the potential association with the cl...

Descripción completa

Detalles Bibliográficos
Autor principal: Ma, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502952/
https://www.ncbi.nlm.nih.gov/pubmed/37720669
http://dx.doi.org/10.3892/ol.2023.14039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502952/
https://www.ncbi.nlm.nih.gov/pubmed/37720669
http://dx.doi.org/10.3892/ol.2023.14039

Ejemplares similares